Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Virchow Biotech is a leading Indian biopharmaceutical company and a key subsidiary of the Virchow Group, headquartered in Hyderabad. The company specializes in the development and large-scale manufacturing of biosimilars, recombinant proteins, and vaccines. It is globally recognized for its robust production capabilities, being part of a group that is the world's largest producer of Sulfamethoxazole. Virchow Biotech's commercial portfolio includes essential treatments for osteoporosis, anemia, and infertility, as well as critical vaccines for infectious diseases. The company operates state-of-the-art facilities that comply with stringent international regulatory standards, including WHO-GMP and US FDA. Through its integrated R&D and manufacturing platforms, Virchow Biotech provides high-quality, affordable healthcare solutions to markets across the globe.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on VirchowTech.